Alcaraz US Open Odds Fall to 26% as Wrist Return Overshadows Sinner Exit

---

Will Alcaraz Win the 2026 US Open? Markets Say Probably Not, and His Wrist Explains Why

Carlos Alcaraz is unlikely to win the 2026 US Open according to prediction markets, which price him at 26% despite his status as second seed and defending champion. He confirmed his participation on August 20 and enters a draw that no longer includes Jannik Sinner, yet his odds have fallen, not risen. His first competitive match action since an April wrist injury was a mixed doubles outing on August 25, five days before singles begins on August 30.

Alcaraz's implied probability of winning the US Open Men's Singles title has fallen from 34% to 26% over three days, an 8-percentage-point decline tracked across Kalshi (25%) and Polymarket (27%). The spread between platforms is tight, confirming this is not a single-venue aberration but a consensus repricing. In a tournament where the top seed just withdrew, the next-best player is losing ground. That inversion tells you everything about how markets weigh injury comeback risk against competitive opportunity.

Prediction-market view

Resolved Sep 13, 2026

Final prices, venue by venue

This market settled on September 13, 2026, so nothing below is tradeable. These are the last prices each venue published before settlement, not live quotes.

---

Sinner's US Open Withdrawal Should Have Been Alcaraz's Moment. The Draw Is Wide Open.

Jannik Sinner, the world No. 1 and 2024 US Open champion, announced on August 21 that he would miss the tournament due to persistent right knee problems. He had not played an official match since winning Wimbledon on July 12. "We've realized I still need more time to recover from my right knee issue," Sinner wrote on social media.

This is the first Grand Slam Sinner has missed since his debut at Wimbledon in 2019. Historically, top-seed withdrawals at majors create a measurable redistribution of implied probability toward the next-highest-ranked contender. Alexander Zverev becomes the top seed with Sinner out. But Alcaraz, as the reigning champion and second seed, is the player most directly positioned to benefit from a bracket that no longer includes the most dominant hard-court player of the past two seasons.

On paper, this is an ideal scenario: the defending champion entering a Grand Slam where his most dangerous rival is absent. The market disagrees. Instead of absorbing the redistributed Sinner probability, Alcaraz has shed 8 percentage points. The draw advantage is real but insufficient to offset the risk profile markets are building around his fitness.

---

Alcaraz's Wrist Injury Is the Real Reason His US Open Chances Are Falling

Alcaraz sustained his right wrist injury in April and has not played a competitive singles match since. That is roughly four months of inactivity for a 23-year-old whose game depends on violent topspin, explosive forehand acceleration, and wrist-intensive shot-shaping. Wrist injuries in tennis are not ankle sprains. They affect the core mechanics of racket-head speed and spin generation, the two attributes that define Alcaraz's playing style.

His first competitive match back was a mixed doubles pairing with Serena Williams on August 25, a 5-3, 4-1 win over Lloyd Glasspool and Erin Routliffe. Mixed doubles is a useful low-stakes environment for testing match readiness, but it bears almost no resemblance to the physical demands of a best-of-five Grand Slam singles draw. Points are shorter, rallies are fewer, and serve-and-volley patterns dominate. It is a confidence builder, not a fitness test.

Alcaraz did show positive signs in training. He beat Holger Rune 7-6 in a practice match, per AS. Practice matches, however, do not replicate the accumulated stress of seven best-of-five matches over two weeks, potentially including three or four against top-20 opponents in the second week. That workload is where a recently recovered wrist becomes a liability rather than a footnote.

The 8-percentage-point decline is markets pricing exactly this scenario: a player who looks ready in controlled settings but faces unknowable risk under Grand Slam intensity. A first-round or second-round exit would not be unprecedented for a returning star; it would be the historical norm.

---

The Case for Alcaraz: Why the Market Could Be Wrong

The strongest counterargument is simple: talent does not disappear in four months, and the draw has never been more favorable. Alcaraz has won Grand Slams on hard courts before, including this very tournament. His mixed doubles victory on August 25 showed clean ball-striking and no visible wrist limitations, even if the format was forgiving. He is only 23, which means his recovery timeline is biologically faster than an older player facing the same situation.

There is also a question of who actually beats him. With Sinner out, the most plausible threats are Zverev (now the top seed) and a handful of next-generation players who have yet to prove they can sustain form over seven rounds. If Alcaraz's wrist holds through the first week, the second week of the draw will be thinner than any he has faced at a major. Markets may be correctly identifying the first-week risk while underpricing the second-week reward.

At 26%, the market is saying Alcaraz has roughly a one-in-four chance. That implies a 74% probability that someone else wins. For a defending champion at a tournament missing its top seed, that is a steep discount. If early-round results show his wrist is functional under match pressure, expect rapid repricing upward. The current price is a bet on uncertainty, not on Alcaraz being unable to compete.

---

What Happens Next: Resolution Timeline and What to Watch

The US Open singles draw begins August 30 and the men's final is scheduled for September 13. The first two rounds, spanning roughly August 30 through September 2, will be the most informative window for Alcaraz's market price. If he moves through the opening rounds without visible discomfort, the injury discount should compress quickly. If he struggles with serve speed, forehand depth, or extended rallies, the 26% price could fall further.

For live pricing on Alcaraz and every other contender, the US Open Men's Singles Winner odds hub tracks Kalshi and Polymarket in real time. This market resolves on September 13 based on the official tournament result.

The bottom line: markets are telling you that a four-month wrist injury and five days of match preparation matter more than a weakened field. That is either a disciplined assessment of comeback risk or a mispricing of the most talented hard-court player in the draw. The first week will tell us which.